Ectonucleotidase and acetylcholinesterase activities in synaptosomes from the cerebral cortex of streptozotocin-induced diabetic rats and treated with resveratrol

Brain Research Bulletin

Volumn 80, Issue 6, 2009, Pages 371-376

  Schmatz, Roberta ^a   Mazzanti, Cinthia Melazzo ^a   Spanevello, Roselia ^a   Stefanello, Naiara ^a   Gutierres, Jessié ^a   Maldonado, Paula Acosta ^a   Corrêa, Maisa ^a   da Rosa, Cíntia Saydelles ^a   Becker, Lara ^a   Bagatini, Margarete ^a   Gonçalves, Jamile Fabbrin ^a   Jaques, Jeandre Dos Santos ^a   Schetinger, Maria Rosa ^a   Morsch, Vera Maria ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Acetylcholinesterase; Diabetes; Ectonucleotidases; Resveratrol; Streptozotocin; Synaptosomes

Indexed keywords

5' NUCLEOTIDASE; ACETYLCHOLINESTERASE; ECTONUCLEOTIDASE; NUCLEOTIDASE; PURINE; RESVERATROL; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DISEASE; BRAIN SYNAPTOSOME; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DOSE COMPARISON; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; MALE; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

5'-NUCLEOTIDASE; ACETYLCHOLINESTERASE; ADENOSINE TRIPHOSPHATASES; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CEREBRAL CORTEX; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; MALE; RANDOM ALLOCATION; RATS; RATS, WISTAR; STILBENES; SYNAPTOSOMES;

EID: 70349947111     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2009.08.019     Document Type: Article

References (55)

1. Agteresch H.J., Dagnelie P.C., and Paul J.H.W. Adenosine triphosphate: established and potential clinical applications. Drugs 58 (1999) 211-232
2. Appleyard M.E. Secreted acetylcholinesterase: non-classical aspects of a classical enzyme. Trends Neurosci. 15 (1992) 485-490
3. Appleyard M.E. Non-cholinergic functions of acetylcholinesterase. Biochem. Soc. Trans. 22 (1994) 749-755
4. Arts I.C.W., and Hollman P.C.H. Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr. 81 (2005) 156-162
5. Arvanitakis Z., Wilson R.S., Bienias J.L., Evans D.A., and Bennett D.A. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch. Neurol. 61 (2004) 661-666
6. Ates O., Cayli S.R., Yucel N., Altinoz E., Kocak A., Duraka M.A., Turkozc Y., and Yologlud S. Central nervous system protection by resveratrol in streptozotocin-induced diabetic rats. J. Clin. Neurosci. 14 (2005) 256-260
7. Bastianetto S., and Quirion R. Natural extracts as possible protective agents of brain aging. Neurobiol. Aging 23 (2002) 891-897
8. Baur J.A., and Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 5 (2006) 493-506
9. Biessels G.J., Deary I.J., and Ryan C.M. Cognition and diabetes: a lifespan perspective. Lancet Neurol. 7 (2008) 184-190
10. 2+ disregulation in diabetes mellitus. Eur. J. Pharmacol. 447 (2002) 201-209
11. Bloomgarden Z.T. Diabetic neuropathy. Diabetes Care 30 (2007) 1027-1032
12. Bradford M.M. A rapid and sensitive method for quantificationof microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
13. Brands A.M.A., Kessels R.P.C., de Haan E.H.F., Kappelle L.J., and Biessels G.J. Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels. Eur. J. Pharmacol. 490 (2004) 159-168
14. Burnstock G. Historical review: ATP as a neurotransmitter. Trends Pharmacol. Sci. 27 (2006) 166-176
15. Chacón M.A., Reyes A.E., and Inestrosa N.C. Acetylcholinesterase induces neuronal cell loss, astrocyte hypertrophy and behavioral deficits in mammalian hippocampus. J. Neurochem. 87 (2003) 195-204
16. 2+-NTPase activity. Anal. Biochem. 157 (1986) 375-378
17. Chang Y., and Wang S.J. Inhibitory effect of glutamate release from rat cerebrocortical nerve terminals by resveratrol. Neurochem. Int. 54 2 (2009) 135-141
18. Cunha R.A., and Ribeiro J.A. ATP as presynaptic modulator. Life Sci. 68 (2000) 119-137
19. Cunha R.A. Adenosine as a neuromodulator and as homeostatic regulator in the nervous system: different role, different sources and different receptors. Neurochem. Int. 38 (2001) 107-125
20. Duarte J.M., Oses J.P., Rodrigues R.J., and Cunha R.A. Modification of purinergic signaling in the hippocampus of streptozotocin-induced diabetic rats. Neuroscience 149 (2007) 382-391
21. Dumwiddie T.V., and Masino S.A. The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 24 (2001) 31-35
22. Ellman G.L., Courtney K.D., Andres Jr. V., and Feather R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7 (1961) 88-95
23. Fields R.D., and Stevens B. ATP: an extracellular signaling molecule between neurons and glia. TINS 23 (2000) 625-633
24. Gibb A., and Halliday F.C. Fast purinergic transmission in the central nervous system. Neuroscience 8 (1996) 225-232
25. Heymann D., Reddington M., and Kreutzberg G.W. Subcellular localization of 5′-nucleotidase in rat brain. J. Neurochem. 43 (1984) 971-978
26. Karuppagounder S.S., Pinto J.T., Xu H., Chen H.L., Beal M.F., and Gibson G.E. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochem. Int. 54 2 (2009) 111-118
27. Kuhad A., Sharma S., and Chopra K. Lycopene attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. Eur. J. Pharmacol. 12 (2008) 624-632
28. Kuhad A., and Chopra K. Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences. Eur. J. Pharmacol. 576 (2007) 34-42
29. Kumar A., Kaundal R.K., and Iyer S. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Life Sci. 80 (2007) 1236-1244
30. Lendvai B., and Vizi E.S. Nonsynaptic chemical transmission through nicotinic acetylcholine receptors. Physiol. Rev. 88 (2008) 333-349
31. Lunkes G.I., Lunkes D.S., Morsch V.M., Mazzanti C.M., Morsch A., Miron V., and Schetinger M. NTPDase and 5′-nucleotidase in rats alloxan-induced diabetes. Diabetes Res. Clin. Pract. 65 (2004) 1-6
32. Mazzanti C.M., Spanevello R.M., Pereira L.B., Gonçalves J.F., Kaizer R., Corrêa M., Ahmed M., Mazzanti A., Festugatto R., Graça D.L., Morsch V.M., and Schetinger M.R.C. Acetylcholinesterase activity in rats experimentally demyelinated with ethidium bromide and treated with interferon beta. Neurochem. Res. 31 (2006) 1027-1032
33. Mesulam M.M., Guillozet A., Shaw P., Levey A., Duysen E.G., and Lockridge O. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience 110 (2002) 627-639
34. Mijnhout G.S., Scheltens P., Diamant M., Biessels G.J., Wessels A.M., Simsek S., Snoek F.J., and Heine R.J. Diabetic encephalopathy: a concept in need of a definition. Diabetologia 49 (2006) 1447-1448
35. Mokni M., Elkahoui S., Limam F., Amri M., and Aouani E. Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. Neurochem. Res. 32 (2007) 981-987
36. Nagy A., and Delgado Escueta A.V. Rapid preparation of synaptosomes from mammalian brain using non-toxic isosmotic gradient material (Percoll). J. Neurochem. 43 (1984) 1114-1123
37. Oses J.P., Cardoso C.M., Germano R.A., Kirst I.B., Rücker B., Fürstenau C.R., Wink M.R., Bonan C.D., Battastini A.M.O., and Sarkis J.J. Soluble NTPDase: an additional system of nucleotide hydrolysis in rat blood serum. Life Sci. 74 (2004) 3275-3284
38. Rathbone M.P., Middlemiss P.J., Gysbers J.W., Andrew C., Herman M.A.R., Reed J.K., Ciccarelli R., Lorio P., and Caciagli F. Trophic effects of purines in neurons and glial cells. Prog. Neurobiol. 59 (1999) 663-690
39. Robson S., Sévigny J., and Zimmermann H. The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal. 2 (2006) 409-430
40. Rocha J.B.T., Emanuelli T., and Pereira M.E. Effects of early undernutrition on kinetic parameters of brain acetylcholinesterase from adult rats. Acta Neurobiol. Exp. 53 (1993) 431-437
41. Saiko P., Szakmary A., Jaeger W., and Szekeres T. Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad?. Mutat Res. Rev. 658 (2008) 68-94
42. Sanchez-Chavez G., and Salceda R. Effect of streptozotocin-induced diabetes on activities of cholinesterases in the rat retina. IUBMB Life 49 (2000) 283-287
43. Schetinger M.R.C., Porto N.M., Moretto M.B., Morsch V.M., da Rocha J.B.T., Vieira V., Moro F., Neis R.T., Bittencourt S., Bonacorso H.G., and Zanatta N. New benzodiazepines alter acetylcholinesterase and ATPDase activities. Neurochem. Res. 25 (2000) 949-955
44. Schetinger M.R., Morsch V.M., Bonan C., and Wyse A. NTPDase and 5′-nucleotidase activities in physiological and disease conditions: new perspectives for human health. Biofactors 31 (2008) 77-98
45. Schmatz R., Mazzanti C.M., Spanevello R., Stefanello N., Gutierres J., Corrêa M., da Rosa M.M., Rubin M.A., Schetinger M.R.C., and Morsch V.M. Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats. Eur. J. Pharmacol. 610 (2009) 42-48
46. Silman I., and Sussman J. Acetylcholinesterase: classical and non classical functions and pharmacology. Curr. Opin. Pharmacol. 5 (2005) 293-302
47. Sima A.A.F., Kamiya H., and Lia Z.G. Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. Eur. J. Pharmacol. 490 (2004) 187-197
48. Soreq H., and Seidman S. Acetylcholinesterase-new roles for and old actor. Nat. Rev. Neurosci. 2 (2001) 294-302
49. Spanevello R.M.M., Mazzanti C.M., Kaizer R., Zanin R., Cargnelutti D., Hannel L., Côrrea M., Mazzanti A., Festugatto R., Graça D., Schetinger M.R.C., and Morsch V. NTPDase and 5′-nucleotidase activities in synaptosomes from the cerebral cortex of rats experimentally demyelinated with ethidium bromide and treated with interferon. Neurochem. Res. 31 (2006) 455-462
50. Sperlágh B., Kittel A., Lajtha A., and Vizi E.S. ATP acts as fast neurotransmitter in rat habenula: neurochemical and enzymecytochemical evidence. Neuroscience 66 (1995) 915-920
51. Sperlágh B., Vizi E., and Wirkner K. P2X7 receptors in the nervous system. Prog. Neurobiol. 78 (2006) 327-346
52. Sträter N. Ecto-5′-nucleotidase: structure function relationships. Purinergic Signal. 2 (2006) 243-350
53. Tõugu V., and Kesvatera T. Role of ionic interactions in cholinesterase catalysis. Biochim. Biophys. Acta 1298 (1996) 12-30
54. Yegutkin G.G. Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. Biochim. Biophys. Acta 1783 (2008) 673-694
55. Zimmermann H. ATP and acetylcholine, equal brethren. Neurochem. Int. 52 (2008) 634-648